Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Overview Rating
Good
Biogen (NASDAQ:BIIB) Stock Quotes, Forecast and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ:BIIB) through any online brokerage.
Who are Biogen (BIIB) competitors?
Other companies in Biogen’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Biogen (BIIB) stock?
Biogen has a consensus price target of $250.89.
What is the current price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $150.395 last updated December 30, 2024 at 12:16 PM EST.
Does Biogen (BIIB) pay a dividend?
There are no upcoming dividends for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q4 earnings are confirmed for Tuesday, February 11, 2025.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.